Tourmaline Bio (TRML) Competitors $14.93 +0.84 (+5.96%) Closing price 04:00 PM EasternExtended Trading$14.70 -0.23 (-1.57%) As of 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TRML vs. INDV, CGON, VERA, SPRY, EWTX, CALT, AMPH, ADPT, ARDX, and EVOShould you be buying Tourmaline Bio stock or one of its competitors? The main competitors of Tourmaline Bio include Indivior (INDV), CG Oncology (CGON), Vera Therapeutics (VERA), ARS Pharmaceuticals (SPRY), Edgewise Therapeutics (EWTX), Calliditas Therapeutics AB (publ) (CALT), Amphastar Pharmaceuticals (AMPH), Adaptive Biotechnologies (ADPT), Ardelyx (ARDX), and Evotec (EVO). These companies are all part of the "pharmaceutical products" industry. Tourmaline Bio vs. Indivior CG Oncology Vera Therapeutics ARS Pharmaceuticals Edgewise Therapeutics Calliditas Therapeutics AB (publ) Amphastar Pharmaceuticals Adaptive Biotechnologies Ardelyx Evotec Indivior (NASDAQ:INDV) and Tourmaline Bio (NASDAQ:TRML) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment, community ranking and analyst recommendations. Which has more risk & volatility, INDV or TRML? Indivior has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, Tourmaline Bio has a beta of 2.14, suggesting that its share price is 114% more volatile than the S&P 500. Does the media prefer INDV or TRML? In the previous week, Indivior and Indivior both had 5 articles in the media. Indivior's average media sentiment score of 1.58 beat Tourmaline Bio's score of 1.07 indicating that Indivior is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Indivior 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Tourmaline Bio 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation and earnings, INDV or TRML? Indivior has higher revenue and earnings than Tourmaline Bio. Indivior is trading at a lower price-to-earnings ratio than Tourmaline Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIndivior$1.19B1.06$2M-$0.35-26.03Tourmaline BioN/AN/A-$42.12M-$2.87-5.20 Is INDV or TRML more profitable? Tourmaline Bio has a net margin of 0.00% compared to Indivior's net margin of -3.96%. Tourmaline Bio's return on equity of -20.97% beat Indivior's return on equity.Company Net Margins Return on Equity Return on Assets Indivior-3.96% -241.73% 15.09% Tourmaline Bio N/A -20.97%-20.56% Do analysts rate INDV or TRML? Indivior presently has a consensus price target of $15.00, indicating a potential upside of 64.65%. Tourmaline Bio has a consensus price target of $45.20, indicating a potential upside of 202.75%. Given Tourmaline Bio's higher possible upside, analysts clearly believe Tourmaline Bio is more favorable than Indivior.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Indivior 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Tourmaline Bio 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of INDV or TRML? 60.3% of Indivior shares are held by institutional investors. Comparatively, 91.9% of Tourmaline Bio shares are held by institutional investors. 11.0% of Tourmaline Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in INDV or TRML? Tourmaline Bio received 10 more outperform votes than Indivior when rated by MarketBeat users. CompanyUnderperformOutperformIndiviorOutperform Votes11100.00% Underperform VotesNo VotesTourmaline BioOutperform Votes21100.00% Underperform VotesNo Votes SummaryTourmaline Bio beats Indivior on 9 of the 16 factors compared between the two stocks. Remove Ads Get Tourmaline Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TRML and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRML vs. The Competition Export to ExcelMetricTourmaline BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$383.48M$2.90B$5.33B$7.57BDividend YieldN/A1.91%5.11%4.32%P/E Ratio-5.2931.0021.7317.81Price / SalesN/A441.17379.2094.61Price / CashN/A168.6838.1534.64Price / Book1.483.476.464.00Net Income-$42.12M-$72.06M$3.20B$247.23M7 Day Performance22.18%9.33%6.54%7.26%1 Month Performance-20.59%-16.97%-8.55%-6.26%1 Year Performance-21.38%-29.10%10.33%-0.18% Tourmaline Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRMLTourmaline Bio2.4493 of 5 stars$14.93+6.0%$45.20+202.7%-30.1%$383.48MN/A-5.2944Gap UpINDVIndivior3.7693 of 5 stars$9.39+2.6%$15.00+59.7%-51.1%$1.29B$1.19B-26.831,164Short Interest ↓Positive NewsCGONCG Oncology1.2398 of 5 stars$16.92-1.6%$63.88+277.5%-49.5%$1.29B$1.14M-11.9261Positive NewsHigh Trading VolumeVERAVera Therapeutics2.9105 of 5 stars$19.94-6.4%$64.67+224.3%-55.2%$1.27BN/A-7.6440News CoverageHigh Trading VolumeSPRYARS Pharmaceuticals3.2812 of 5 stars$12.83+0.2%$31.00+141.6%+60.4%$1.26B$89.15M-25.1690Gap DownHigh Trading VolumeEWTXEdgewise Therapeutics2.064 of 5 stars$11.83+2.8%$40.38+241.3%-24.7%$1.24BN/A-7.8960High Trading VolumeCALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180AMPHAmphastar Pharmaceuticals4.2953 of 5 stars$25.00-6.1%$43.50+74.0%-38.4%$1.19B$731.97M8.331,620News CoveragePositive NewsHigh Trading VolumeADPTAdaptive Biotechnologies3.2591 of 5 stars$7.70+3.1%$9.40+22.1%+159.8%$1.14B$178.96M-7.06790Positive NewsHigh Trading VolumeARDXArdelyx4.2132 of 5 stars$4.45-2.2%$10.61+138.5%-35.3%$1.06B$333.62M-27.8190EVOEvotec1.4337 of 5 stars$2.97-2.9%$5.93+99.8%-54.7%$1.05B$777.05M0.004,200Upcoming EarningsGap Up Remove Ads Related Companies and Tools Related Companies Indivior Alternatives CG Oncology Alternatives Vera Therapeutics Alternatives ARS Pharmaceuticals Alternatives Edgewise Therapeutics Alternatives Calliditas Therapeutics AB (publ) Alternatives Amphastar Pharmaceuticals Alternatives Adaptive Biotechnologies Alternatives Ardelyx Alternatives Evotec Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRML) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tourmaline Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TRML Stock Free TRML Stock Alerts